BIOCONTROL TECHNOLOGY INC
8-K, 1999-07-02
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: AFL CIO HOUSING INVESTMENT TRUST, N-30B-2, 1999-07-02
Next: FEDERAL SIGNAL CORP /DE/, 11-K, 1999-07-02





               SECURITIES AND EXCHANGE COMMISSION

                     Washington, D.C.  20549

                            FORM 8-K

                         CURRENT REPORT

             Pursuant to Section 13 or 15(d) of the
                 Securities Exchange Act of 1934

                       ___________________


     Date of Report (Date of earliest event reported) June 24, 1999

                    BIOCONTROL TECHNOLOGY, INC.
       (Exact name of registrant as specified in its charter)


   Pennsylvania                   0-10822                   25-1229323
 (State of other jurisdiction  (Commission File Number)    (IRS Employer
   of incorporation)                                      Identification No.)



            300 Indian Springs Road, Indiana, Pennsylvania 15701
           (Address of principal executive offices)     (Zip Code)


      Registrant's telephone number, including area code (412) 349-1811



_________________________________________________________________
                 (Former name or former address,
                  if changes since last report.)







Item 1.   Change in Control of Registrant.
          Not applicable.

Item 2.   Acquisition or Disposition of Assets.
          Not applicable.

Item 3.   Bankruptcy or Receivership.
          Not applicable.

Item 4.   Changes in Registrant's Certifying Accountant
          Not applicable.

Item 5.   Other Events.

          Biocontrol Technology, Inc. announced today in response
          to the recent drop in its stock value that nothing
          material to the Company has occurred to cause such a
          decline.  The Company is in a solid financial position
          and the Diasensor, Petrol Rem, and IDT subsidiaries are
          all making excellent progress with their respective
          projects and have added directors highly respected in
          their fields.  Biocontrol has had an 18% increase in
          its staff with 6% being rehires of staff laid off at
          the end of 1998 or beginning of 1999.

Item 6.   Resignation of Registrant's Directors.
          Not Applicable

Item 7.   Financial Statement, Pro Forma Financial Information
          and Exhibits.

          (a)  Financial Statements and Businesses Acquired - Not
               Applicable.

          (b)  Pro Forma Financial Information - Not Applicable.

          (c)  Exhibits - Press Release.

                           SIGNATURES

      Pursuant to the requirement of the Securities Exchange  Act
of  1934, the Registrant has duly caused this Report to be signed
on its behalf by the undersigned hereunto duly authorized.

                                   BIOCONTROL TECHNOLOGY, INC.

                                   by  /s/   Fred E. Cooper
                                             Fred E. Cooper, CEO

DATED:  June 24, 1999


                                        BICO
                            BIOCONTROL TECHNOLOGY, INC
                            2275 Swallow Hill Road, Building 2500
                                Pittsburgh, PA  15220
Press Release

Investors                                      Media
Diane McQuaide                                 Susan Taylor
1.412.429.0673  phone                          1.412.429.0673 phone
1.412.279.9690  fax                            1.412.279.5041 fax


         BIOCONTROL SAYS NO MATERIAL REASON FOR STOCK DROP

     Pittsburgh, PA - June 24, 1999 - Biocontrol Technology, Inc.
(OTCBB:BICO)  announced today in response to the recent  drop  in
its stock value that nothing material to the Company has occurred
to cause such a decline.
     On  the  contrary,  the  Company is  in  a  solid  financial
position and the Diasensor, Petrol Rem, and IDT subsidiaries  are
all  making excellent progress with their respective projects and
have  added  directors highly respected in their  fields.   Also,
Biocontrol  has had an 18% increase in its staff  with  6%  being
rehires  of  staff laid off at the end of 1998  or  beginning  of
1999.
     On  May  24, 1999, the first module of Biocontrol's  modular
premarket approval application (PMA) submission for the Diasensor
2000  was  submitted to the FDA, which has 90 days  in  which  to
respond.   Biocontrol  continues to move forward  on  the  second
module  and  the  enhancements  to  the  operating  software  and
hardware  necessary  for the telemedicine program  utilizing  the
Diasensor 2000.
     The Diasensor 2000 is a home-use instrument used by patients
with diabetes to measure their blood glucose without the need  to
prick  the  finger  to  obtain a drop of blood.   Patients  using
currently  marketed invasive devices require that patients  prick
their  fingers to obtain a sample of blood to test their glucose.
The  Diasensor 2000 illuminates a small area on the patient's arm
with infrared light, which is then scattered back out through the
skin  and  collected  by  the instrument.   This  information  is
interpreted  by  software in the instrument as  a  blood  glucose
concentration.
     Biocontrol   Technology  has  its  corporate   offices   in
Pittsburgh, PA and is involved in the development and manufacture
of  biomedical  devices and environmental  products.   Subsidiary
Diasensor.com, Inc., also located in Pittsburgh, PA, markets  the
Diasensor.    Diasensor.com  owns  the  patent,   marketing   and
distribution  rights  to  the sensor  while  Biocontrol  has  the
exclusive   rights   to   the  research   and   development   and
manufacturing of the sensor.
WEBSITE:  www.bico.com
INVESTOR RELATIONS NEWSLINE NUMBER:  1.800.357.6204



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission